Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

September 01, 1979; Volume 16,Issue 2

Articles

  • You have access
    Molecular Requirements for Recognition at a Glucoreceptor for Insulin Release
    DANIEL C. WEAVER, C. DAVID BARRY, MICHAEL L. MCDANIEL, GARLAND R. MARSHALL and PAUL E. LACY
    Molecular Pharmacology September 1979, 16 (2) 361-368;
  • You have access
    The Conformation of Dopamine at Its Receptor: Binding of Monohydroxy-2-aminotetralin Enantiomers and Positional Isomers
    J. L. TEDESCO, P. SEEMAN and J. D. MCDERMED
    Molecular Pharmacology September 1979, 16 (2) 369-381;
  • You have access
    Mode of Action of Quinacrine on the Acetylcholine Receptor Ionic Channel Complex
    M.-C. TSAI, A. C. OLIVEIRA, E. X. ALBUQUERQUE, M. E. ELDEFRAWI and A. T. ELDEFRAWI
    Molecular Pharmacology September 1979, 16 (2) 382-392;
  • You have access
    Physicochemical Basis of Opiate-Cerebroside Sulfate Interaction and Its Application to Receptor Theory
    TAE MOOK CHO, JUNG SOOK CHO and HORACE H. LOH
    Molecular Pharmacology September 1979, 16 (2) 393-405;
  • You have access
    Action of Histamine on Cyclic AMP in Guinea Pig Gastric Cells: Inhibition by H1- and H2-Receptor Antagonists
    SHMUEL BATZRI and JERRY D. GARDNER
    Molecular Pharmacology September 1979, 16 (2) 406-416;
  • You have access
    Studies on Histamine H2 Receptors Coupled to Cardiac Adenylate Cyclase
    CARL L. JOHNSON, HAREL WEINSTEIN and JACK PETER GREEN
    Molecular Pharmacology September 1979, 16 (2) 417-428;
  • You have access
    High Efficiency Coupling Between Beta-adrenergic Receptors and Cardiac Contractility: Direct Evidence for "Spare" Beta-adrenergic Receptors
    J. CRAIG VENTER
    Molecular Pharmacology September 1979, 16 (2) 429-440;
  • You have access
    Distribution and Function of Adrenergic Receptors in the Urinary Bladder of the Rabbit
    ROBERT M. LEVIN and ALAN J. WEIN
    Molecular Pharmacology September 1979, 16 (2) 441-448;
  • You have access
    Coordinate Protein Kinase Activation and Specific Enzyme Induction by Cyclic Nucleotide Derivatives in Intact Cultured Hepatoma Cells
    JAYANTHA WIMALASENA and WESLEY D. WICKS
    Molecular Pharmacology September 1979, 16 (2) 449-461;
  • You have access
    Adenylate Cyclase in Cerebral Microvessels: Action of Guanine Nucleotides, Adenosine, and other Agonists
    MINTA HUANG and GEORGE I. DRUMMOND
    Molecular Pharmacology September 1979, 16 (2) 462-472;
  • You have access
    Response of Adenosine Cyclic 3',5'-Monophosphate Level in Rabbit Neutrophils to the Chemotactic Peptide Formyl-Methionyl-Leucyl-Phenylalanine
    SUZANNE JACKOWSKI and R. I. SHA'AFI
    Molecular Pharmacology September 1979, 16 (2) 473-481;
  • You have access
    Regulation of Synthesis and Degradation of Rat Adrenal Phenylethanolamine N-methyltransferase
    DAVID M. BERENBEIM, DONA L. WONG, STEVEN J. MASOVER and ROLAND D. CIARANELLO
    Molecular Pharmacology September 1979, 16 (2) 482-490;
  • You have access
    Regulation of Synthesis and Degradation of Rat Adrenal Phenylethanolamine N-methyltransferase
    STEVEN J. MASOVER, DAVID M. BERENBEIM and ROLAND D. CIARANELLO
    Molecular Pharmacology September 1979, 16 (2) 491-503;
  • You have access
    Regulation of Rat Heart Ornithine Decarboxylase: Change in Affinity for Ornithine Evoked by Neuronal, Hormonal, and Ontogenetic Stimuli
    CHRISTOPHER LAU and THEODORE A. SLOTKIN
    Molecular Pharmacology September 1979, 16 (2) 504-512;
  • You have access
    The Rapid Activation of Adrenal Tyrosine Hydroxylase by Decapitation and its Relationship to a Cyclic AMP-dependent Phosphorylating Mechanism
    JOSEPH M. MASSERANO and NORMAN WEINER
    Molecular Pharmacology September 1979, 16 (2) 513-528;
  • You have access
    Human Pheochromocytoma Dopamine-Beta-Hydroxylase: Purification and Molecular Parameters of the Tetramer
    DANIEL T. O'CONNOR, RONALD P. FRIGON and RICHARD A. STONE
    Molecular Pharmacology September 1979, 16 (2) 529-538;
  • You have access
    Molecular Basis for the Irreversible Inhibition of 4-Aminobutyric Acid:2-Oxoglutarate and L-Ornithine:2-Oxoacid Aminotransferases by 3-Amino-1,5-Cyclohexadienyl Carboxylic Acid (Isogabaculine)
    BRIAN W. METCALF and MICHEL J. JUNG
    Molecular Pharmacology September 1979, 16 (2) 539-545;
  • You have access
    The Inhibition of Rat Heart Type A Monoamine Oxidase by Clorgyline as a Method for the Estimation of Enzyme Active Centers
    CHRISTOPHER J. FOWLER and BRIAN A. CALLINGHAM
    Molecular Pharmacology September 1979, 16 (2) 546-555;
  • You have access
    Structure/Activity Studies of Flavonoids As Inhibitors of Cyclic AMP Phosphodiesterase and Relationship to Quantum Chemical Indices
    JAMES E. FERRELL, PETER D. G. CHANG SING, GILDA LOEW, ROY KING, JOAN M. MANSOUR and TAG E. MANSOUR
    Molecular Pharmacology September 1979, 16 (2) 556-568;
  • You have access
    Effects of Phorbol Ester Tumor Promoters on Arachidonic Acid Metabolism in Chick Embryo Fibroblasts
    R. A. MUFSON, D. DEFEO and I. B. WEINSTEIN
    Molecular Pharmacology September 1979, 16 (2) 569-578;
  • You have access
    The Effects of Some Organic "Calcium Antagonists" on Calcium Influx in Presynaptic Nerve Terminals
    D. A. NACHSHEN and M. P. BLAUSTEIN
    Molecular Pharmacology September 1979, 16 (2) 579-586;
  • You have access
    Active Transport of Methadone in Synaptosomes
    ANNE L. CAHILL, MARK P. HOORNSTRA and FEDOR MEDZIHRADSKY
    Molecular Pharmacology September 1979, 16 (2) 587-600;
  • You have access
    Thymidine Induced Perturbations in Ribonucleoside and Deoxyribonucleoside Triphosphate Pools in Human Leukemic CCRF-CEM Cells
    GERALD B. GRINDEY, MING C. WANG and JAMES J. KINAHAN
    Molecular Pharmacology September 1979, 16 (2) 601-606;
  • You have access
    Deoxyuridine Incorporation as a Useful Measure of Methotrexate and Metoprine Uptake and Metabolic Effectiveness
    W. DAVID SEDWICK, MARY JO FYFE, OLIVER E. BROWN, THOMAS A. FRAZER, MARC KUTLER and JOHN LASZLO
    Molecular Pharmacology September 1979, 16 (2) 607-613;
  • You have access
    Poly (L-Lysine) and Poly (D-Lysine) Conjugates of Methotrexate: Different Inhibitory Effect on Drug Resistant Cells
    WEI-CHIANG SHEN and HUGUES J.-P. RYSER
    Molecular Pharmacology September 1979, 16 (2) 614-622;
  • You have access
    DNA Binding Studies on Several New Anthracycline Antitumor Antibiotics II. The Importance of the Carbomethoxy-group at Position-10 of the Class II Anthracycline Molecule
    VIRGIL H. DUVERNAY, JONATHAN A. PACHTER and STANLEY T. CROOKE
    Molecular Pharmacology September 1979, 16 (2) 623-632;
  • You have access
    Metabolic Activation of Polycyclic Aromatic Carcinogens: A Theoretical Study
    ROBERT S. UMANS, MARK KORUDA and D. J. SARDELLA
    Molecular Pharmacology September 1979, 16 (2) 633-642;
  • You have access
    The Highly Tumorigenic 3,4-Dihydrodiol Is a Principal Metabolite Formed from Dibenzo[a,h]anthracene by Liver Enzymes
    M. NORDQVIST, D. R. THAKKER, W. LEVIN, H. YAGI, D. E. RYAN, P. E. THOMAS, A. H. CONNEY and D. M. JERINA
    Molecular Pharmacology September 1979, 16 (2) 643-655;
  • You have access
    The Epoxide Hydratase Inducer Trans-Stilbene Oxide Shifts the Metabolic Epoxidation of Benzo(a)pyrene from the Bay- to the K-Region and Reduces Its Mutagenicity
    M. BÜCKER, M. GOLAN, H. U. SCHMASSMANN, H. R. GLATT, P. STASIECKI and F. OESCH
    Molecular Pharmacology September 1979, 16 (2) 656-666;
  • You have access
    Involvement of Phenolic Metabolites in the Irreversible Protein-Binding of Aromatic Hydrocarbons: Reactive Metabolites of [14C]Naphthalene and [14C]1-Naphthol Formed by Rat Liver Microsomes
    SIGRUN HESSE and MARGOT MEZGER
    Molecular Pharmacology September 1979, 16 (2) 667-675;
  • You have access
    Spin Trapping of Superoxide
    ELI FINKELSTEIN, GERALD M. ROSEN, ELMER J. RAUCKMAN and JOHN PAXTON
    Molecular Pharmacology September 1979, 16 (2) 676-685;
  • You have access
    Molecular Toxicology of (-)-erythro-Fluorocitrate: Selective Inhibition of Citrate Transport in Mitochondria and the Binding of Fluorocitrate to Mitochondrial Proteins
    E. Kirsten, M. L. Sharma and E. Kun
    Molecular Pharmacology September 1979, 16 (2) 686;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 16, Issue 2
1 Sep 1979
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Sign up for alerts

Jump to

  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics